Company Filing History:
9 out of 3,580 
1 out of 1 Years Active: 1976-1986
Title: Arthur K Hoffmann: A Pioneer in Chemical Synthesis and Anthelmintic Development
Introduction
Arthur K Hoffmann, based in New Canaan, CT, is an accomplished inventor with an impressive portfolio of 10 patents. His work primarily focuses on the synthesis of compounds that are essential in the manufacturing of anthelmintics, particularly tetramisole and levamisole, which play a critical role in veterinary and medical applications.
Latest Patents
Hoffmann's latest patents showcase his innovative processes in the synthesis of key intermediates. These patents include the synthesis of intermediates for tetramisole and levamisole, along with detailed methodologies for manufacturing various derivatives such as 1-(2-alkoxyethyl)-4-phenyl-4-imidazolin-2-ones, 1-(2-alkoxyethyl)-4-phenyl-2-imidazolidones, and 1-(2-alkoxyethyl)-4-phenyl-imidazolidine-2-thiones. These compounds serve as vital intermediates in new processes for manufacturing tetramisole and its derivatives, aiming to enhance the efficacy and efficiency of anthelmintics.
Career Highlights
Throughout his career, Hoffmann has made significant contributions to the field of medicinal chemistry. He has collaborated with major companies such as American Cyanamid Company and Cyanamid Agricultural de Puerto Rico, Inc., where he developed innovative processes that have impacted pharmaceutical manufacturing. His work not only emphasizes the significance of chemical compounds but also underscores advancements in the synthesis of anthelmintics.
Collaborations
Hoffmann has worked alongside notable colleagues in his field, including Sivaraman Raghu and Balwant Singh. Their collaborative efforts have furthered research and development in the realm of chemical synthesis, leading to groundbreaking discoveries and improvements in pharmaceutical applications.
Conclusion
Arthur K Hoffmann's contributions to the field of medicinal chemistry exemplify the spirit of innovation. His patents have advanced the synthesis of critical compounds that address important health issues, showcasing the vital role inventors play in the development of effective treatments. Hoffmann's legacy lies in his relentless pursuit of innovation and collaboration in the pharmaceutical industry.